| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |